Nguyen Thao P, Sieg Scott F
Department of Medicine, Department of Pathology, Division of Infectious Diseases and HIV Medicine, Case Western Reserve University/University Hospitals Case Medical Center, Cleveland, Ohio, USA.
Department of Medicine, Department of Pathology, Division of Infectious Diseases and HIV Medicine, Case Western Reserve University/University Hospitals Case Medical Center, Cleveland, Ohio, USA
J Leukoc Biol. 2017 Aug;102(2):499-506. doi: 10.1189/jlb.3A1216-520RR. Epub 2017 Jun 6.
TGF-β is a potent suppressor of T cell activation and expansion. Although the antiproliferative effects of TGF-β are well characterized in TCR-activated cells, the effects of TGF-β on T cell proliferation driven by homeostatic cytokines, such as IL-7, are poorly defined. In the current study, we found that TGF-β inhibits IL-7-induced proliferation in memory, but not in naive human CD4 T cells. TGF-β impaired c-myc induction in all CD4 T cell maturation subsets, although the impairment was less sustained in naive CD4 T cells. TGF-β had no discernible effect on IL-7R signaling (p-STAT-5, p-Akt, or p-S6) in memory T cells but selectively enhanced p-S6 signaling in naive T cells. The inhibitory effects of TGF-β on memory T cell proliferation were partially overcome by chemical inhibition of GSK-3, which also led to enhanced c-myc expression. These data suggest that TGF-β could play an important role in limiting homeostatic proliferation of memory T cells. Our observations also point toward a novel strategy to subvert TGF-β-mediated inhibition of memory T cells by targeting GSK-3 for inhibition.
转化生长因子-β(TGF-β)是T细胞活化和增殖的强效抑制剂。尽管TGF-β的抗增殖作用在T细胞受体(TCR)激活的细胞中已得到充分表征,但TGF-β对由稳态细胞因子(如白细胞介素-7,IL-7)驱动的T细胞增殖的影响仍不清楚。在本研究中,我们发现TGF-β抑制记忆性人类CD4 T细胞中IL-7诱导的增殖,但不抑制初始CD4 T细胞中的增殖。TGF-β损害了所有CD4 T细胞成熟亚群中c-myc的诱导,尽管在初始CD4 T细胞中这种损害持续时间较短。TGF-β对记忆性T细胞中的IL-7R信号传导(磷酸化信号转导子和转录激活子5,p-STAT-5;磷酸化蛋白激酶B,p-Akt;或磷酸化核糖体蛋白S6,p-S6)没有明显影响,但选择性增强了初始T细胞中的p-S6信号传导。通过化学抑制糖原合成酶激酶-3(GSK-3)可部分克服TGF-β对记忆性T细胞增殖的抑制作用,这也导致c-myc表达增强。这些数据表明,TGF-β可能在限制记忆性T细胞的稳态增殖中发挥重要作用。我们的观察结果还指向一种新策略,即通过靶向抑制GSK-3来颠覆TGF-β介导的对记忆性T细胞的抑制作用。